Latin American trading block approves harmonised GMP rules for medtech
This article was originally published in SRA
Executive Summary
In a significant move for medtech manufacturing across Latin America, the Mercosur trading bloc has approved measures to harmonise the inspection and certification of manufacturers of medical devices and in vitro diagnostics1. The bloc’s five member states – Argentina, Brazil, Paraguay, Uruguay and Venezuela – are to transpose a series of good-manufacturing practice (GMP) compliance procedures into national law by the end of April 2013.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.